215
订阅者
无数据24 小时
无数据7 天
+1530 天
数据加载中...
吸引订阅者
九月 '24
九月 '24
+3
在0个频道中
八月 '24
+240
在1个频道中
Get PRO
七月 '240
在0个频道中
Get PRO
六月 '240
在1个频道中
Get PRO
五月 '240
在2个频道中
Get PRO
四月 '240
在0个频道中
Get PRO
三月 '240
在0个频道中
Get PRO
二月 '24
+7
在0个频道中
Get PRO
一月 '24
+9
在0个频道中
Get PRO
十二月 '23
+209
在0个频道中
| 日期 | 订阅者增长 | 提及 | 频道 | |
| 25 九月 | 0 | |||
| 24 九月 | 0 | |||
| 23 九月 | 0 | |||
| 22 九月 | 0 | |||
| 21 九月 | 0 | |||
| 20 九月 | 0 | |||
| 19 九月 | 0 | |||
| 18 九月 | 0 | |||
| 17 九月 | +1 | |||
| 16 九月 | 0 | |||
| 15 九月 | 0 | |||
| 14 九月 | 0 | |||
| 13 九月 | 0 | |||
| 12 九月 | 0 | |||
| 11 九月 | +1 | |||
| 10 九月 | 0 | |||
| 09 九月 | +1 | |||
| 08 九月 | 0 | |||
| 07 九月 | 0 | |||
| 06 九月 | 0 | |||
| 05 九月 | 0 | |||
| 04 九月 | 0 | |||
| 03 九月 | 0 | |||
| 02 九月 | 0 | |||
| 01 九月 | 0 |
频道帖子
| 2 | Post-Partum Hemorrhage: AMBOSSQs Pearls | 168 |
| 3 |  Case Files: Obstetrics; IUGR | 180 |
| 4 | Case Files: Obstetrics; IUGR | 177 |
| 5 | Case Files: Obstetrics ; Fetal Bradycardia | 176 |
| 6 | Obstetrics by Ten Teachers ll Eclampsia | 167 |
| 7 | Approach to shoulder dystocia ll UpToDate | 266 |
| 8 | Normal labor and delivery: AMBOSSQs Pearls | 192 |
| 9 | Case Files: Obstetrics ; Diabetes in pregnancy | 230 |
| 10 | Case Files: Obstetrics ; Diabetes in pregnancy | 212 |
| 11 | Screening for sickle cell disease | 260 |
| 12 | Secondary Sjögren syndrome may develop in as many as 40%–65% of patients with primary biliary cirrhosis (PBC). Typical symptoms include dry mouth (xerostomia) and dry eyes (keratoconjunctivitis) and may precede PBC-related symptoms. | 213 |
| 13 | 没有文字... | 190 |
| 14 | In addition to its use in sickle cell anemia, Hydroxyurea is also used in the treatment of polycythemia vera and other myeloproliferative disorders.
In these conditions, hydroxyurea is beneficial because of its myelosuppressive effects, which are a result of its inhibition of ribonucleoside diphosphate reductase.
#Sickle_cell | 184 |
| 15 | 没有文字... | 243 |
| 16 |  没有文字... | 188 |
| 17 | https://youtu.be/8k0HZutTsP8?si=k4xoiGx4alSeGkbs | 212 |
| 18 | Anti hypertensive drug choice in ICH
For most patients with an initial SBP ≥160 mmHg, we prefer nicardipine for initial treatment because it is fast-acting and can be quickly titrated.
Blood pressure is monitored every five minutes and patients are monitored at least hourly to assess for neurologic deterioration.
For most patients with an initial SBP <160 mmHg, we start with labetalol for its ease of administration and long duration of effect.
🚨🚨
Nitroprusside and nitroglycerin are typically avoided because they may increase intracranial pressure.
UpToDate. | 165 |
| 19 | Reducing SBP below 130 mmHg in the first hours after ICH onset has not been shown clearly beneficial for reducing death or disability and may increase the risk of adverse events, including cerebral hypoperfusion and kidney injury.
UpToDate. | 115 |
| 20 | Blood pressure management in ICH
For patients with acute ICH who present with systolic blood pressure (SBP) between 150 and 220 mmHg, we suggest lowering of SBP to a target of 140 mmHg, ideally within the first one hour of presentation, provided the patient remains clinically stable.
This degree of blood pressure reduction appears safe in most patients and may improve functional outcome.
For patients with acute ICH who present with SBP >220 mmHg, we suggest rapid lowering of SBP to <220 mmHg. Thereafter, the blood pressure is gradually reduced (over a period of hours) to a target range of 140 to 160 mmHg, provided the patient remains clinically stable.
Patients who deteriorate clinically during this period may require reduction of acute antihypertensive therapy.
The optimal blood pressure goal is uncertain, but an SBP of 140 to 160 mmHg is a reasonable target for patients who remain clinically stable. | 134 |
